Abiopharma

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Live Oak Bank Appoints Matthew S. Diffley as Chief Accounting Officer

Morningstar, Inc. to Announce Second-Quarter 2026 Financial Results on July 29

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Hyperliquid Strategies Inc Added to the Russell 3000, Russell 2000 and S&P Global BMI Indices

Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

Universal Display Corporation’s Dr. Julie Brown Receives Prestigious IEEE Frederik Philips Award

Pathfinder Bancorp, Inc. Declares Dividend

BRAEMAR HOTELS & RESORTS EXTENDS RITZ-CARLTON LAKE TAHOE MORTGAGE LOAN

DHT Holdings, Inc. Announces Fleet Upgrades and Charter Management